BridgeBio Pharma grants 147,578 restricted stock units to 80 new employees
BBIO•BridgeBio Pharma approved restricted stock units covering 147,578 common shares for 80 new employees on November 5, 2026.
1. Award vesting schedule
One-fourth of each award vests on November 16, 2027, with one-twelfth of the remaining shares vesting quarterly thereafter. Vesting requires continued employment with BridgeBio Pharma or one of its subsidiaries on each vesting date.
